“maybe someone should contact someone like Ellen
Post# of 148313
Is there a reason you chose Ellen? Has she started investigating biotech companies and promoting them on her show? Probably not and it’s ridiculous to think she would. Combo for HIV is great, but mono and the other indications (Cancer, NASH, and GvHD) are where the money is and each of those indications is early in phase 2 or hasn’t started a human trial yet. Ellen or any major news agency could care less about CYDY and leronlimab at this point.
Nearly every biotech investor board has a member or two encouraging others to contact the news or such and such show about their respective companies drug and why it will save everyone. I can’t think of a situation when it actually worked, especially because most drugs haven’t been approved yet. Good results in cancer will make leronlimab and CYDY a household name, until then, we play the waiting game for financing to get us to BLA submission.